TABLE OF CONTENTS
Volume 12, Issue 3 (April 2006)
Editorial
Editorial: Finding the Holy Grail in a grain of rice
Henry I Miller
J Commer Biotechnol 12: 173-174; doi:10.1057/palgrave.jcb.3040163
Papers
Pitfalls of valuation in biotech
Ralph Villiger and Boris Bogdan
J Commer Biotechnol 12: 175-181; doi:10.1057/palgrave.jcb.3040164
The SEC's enforcement programme on biotechnology's communications with the investment community
Arthur S Gabinet
J Commer Biotechnol 12: 182-191; doi:10.1057/palgrave.jcb.3040165
Commercial biotechnology in Latin America: Current opportunities and challenges
Fernando Quezada
J Commer Biotechnol 12: 192-199; doi:10.1057/palgrave.jcb.3040166
Research collaboration and development of intellectual property with the University of Southampton in the field of asthma and COPD
Stephen Holgate and Sue Edwards
J Commer Biotechnol 12: 200-204; doi:10.1057/palgrave.jcb.3040167
Bioethical concerns in Japanese biotechnology companies
Makina Kato and Darryl Macer
J Commer Biotechnol 12: 205-212; doi:10.1057/palgrave.jcb.3040168
Spin-out fever: Spinning out a University of Oxford company and comments on the process in other universities
Bruce Savage
J Commer Biotechnol 12: 213-219; doi:10.1057/palgrave.jcb.3040169
Winning the game: Public funds for biotech companies
Michael Gollin, Eva Jack, Terry Chase, Jesus Soriano and Robert Smith
J Commer Biotechnol 12: 220-228; doi:10.1057/palgrave.jcb.3040170
Strategic alliances as a mechanism for wealth creation in the biopharmaceutical industry: An empirical analysis of the Spanish case
Emma Gutiérrez de Mesa Vázquez, Juan Angel Jiménez Martín and Juan Mascareñas
J Commer Biotechnol 12: 229-236; doi:10.1057/palgrave.jcb.3040171
Autoimmune and inflammatory disorder biologicals will power biotech market growth through to 2010
Clare A C Churchill and Mark J Belsey
J Commer Biotechnol 12: 237-241; doi:10.1057/palgrave.jcb.3040172
